MONICA MARTINEZ: Open Payments
NPI 1912671298 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 21 payments from 13 companies in 2025. Trend: 2023 $1,641 · 2024 $334 · 2025 $826
Food & beverage: $635Education: $190
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $273 |
| Astellas Pharma US Inc | 2 | $190 |
| Amgen Inc. | 2 | $91 |
| Biogen, Inc. | 3 | $56 |
| Exeltis, USA Inc. | 2 | $36 |
| SHIELD THERAPEUTICS INC | 1 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $30 |
| Neuronetics, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $23 |
| Solventum Corporation | 1 | $19 |
Products named: Wegovy, EVENITY, ZURZUVAE, SLYND, ACCRUFER, GEMTESA, NEUROSTAR TMS THERAPY SYSTEM, LILETTA.
Industry payments across UT — which companies pay providers there.
